Oral Hammaslaakarit Oyj Stock

Stocks

Delayed Nasdaq Helsinki			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-

Manager	Title	Age	Since
Jarkko Olavi Jokinen CEO	Chief Executive Officer	-	01/06/2019
Thomas Mount DFI	Director of Finance/CFO	-	-
Petra Kari CTO	Chief Tech/Sci/R&D Officer	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ORAL HAMMASLAAKARIT OYJ	-.--%	-.--%	-	-	0
CVS HEALTH CORPORATION	-1.29%	-3.75%	+9.43%	+35.69%	117B
HCA HEALTHCARE, INC.	+2.95%	+0.83%	-0.69%	+105.61%	97.42B
NATERA, INC.	+3.31%	+2.67%	+123.89%	+1,009.30%	59.22B
FRESENIUS SE & CO. KGAA	+0.17%	+1.62%	-6.81%	+89.51%	29.03B
LABCORP HOLDINGS INC.	+8.78%	+11.27%	+38.72%	+81.07%	26.86B
QUEST DIAGNOSTICS INCORPORATED	+1.26%	+2.80%	+37.77%	+92.37%	26.69B
TENET HEALTHCARE CORPORATION	+2.46%	-0.23%	+31.22%	+405.46%	21.1B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.95%	+3.67%	-17.37%	-0.93%	20.61B
IHH HEALTHCARE	-0.13%	-1.39%	-5.43%	+31.16%	16.94B
Average	+1.85%	-0.26%	+23.41%	+205.47%	46.05B
Weighted average by Cap.	+1.63%	-1.40%	+25.16%	+218.43%